谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

The FNTB Promoter Polymorphism Rs11623866 As a Potential Predictive Biomarker for Lonafarnib Treatment of Ovarian Cancer Patients

Hagen Sjard Bachmann,Werner Meier,Andreas du Bois,Rainer Kimmig,Jan Dominik Kuhlmann,Winfried Siffert,Jalid Sehouli,Kerstin Wollschlaeger,Jens Huober,Peter Hillemanns,Alexander Burges,Barbara Schmalfeldt,Behnaz Aminossadati,Pauline Wimberger

BJCP British journal of clinical pharmacology/British journal of clinical pharmacology（2015）

引用 6|浏览24
暂无评分
关键词
farnesyltransferase inhibitor,lonafarnib,ovarian cancer,rs11623866,single nucleotide polymorphism
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要